EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS
Abstract
Article Retracted
Downloads
Download data is not yet available.
References
Article Retracted
Published
01-03-2017
How to Cite
Retracted, A. “EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 3, Mar. 2017, pp. 300-7, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/16213.
Issue
Section
Original Article(s)
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.